In addition, we also found significant decrease in RANKL expression of RA CD4+ T cells with p-Akt1 inhibition (Figure 8K) and report statistical significance in all the tested batches (Figures 8F, H, I, J, L). The gene discussed is AKT1; the disease is rheumatoid arthritis.